EW
EW
Edwards Lifesciences Corp
$85.11
-0.76%
$49.0B
No data for this timeframe.
Vol
Market Cap$49.0B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (74%)
Inst. Holders50 funds
Inst. Value$25.7B
Inst. Activity37 buys / 13 sells
Insider Activity0B / 7S
Insider Net $-$3.2M
Reddit Sentiment38° Cool
SEC Reports13
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0001099800·Prev Close $85.76
Recent Activity
Jun 2, 2026
short_volume
Short Volume: EW — 55.6% short (1.1M / 1.9M)
Short: 1,075,044 | Exempt: 37 | TRF Vol: 1,933,965 | Short Ratio: 55.6% | Off-exchange volume (dark
May 29, 2026
SEC
Three Edwards Lifesciences insiders sold a total of ~$2.18M in open-market sales over a 7-day window, led by the CVP of
CLUSTER — Impact 2/10
May 29, 2026
Insider
Dahl Andrew M. sold 567.527 shares
SVP, Corporate Controller @ $86.08 ($48.9K)
May 27, 2026
Insider
BOBO DONALD E JR sold 23,145 shares
CVP,Strategy/Corp Development @ $86.42 ($2.0M)
May 22, 2026
Insider
Chopra Daveen sold 1,500 shares
CVP, TMTT & Surgical @ $84.60 ($126.9K)
May 18, 2026
SEC
Four Edwards Lifesciences insiders sold a total of $982K in stock over a week, with the largest sale by CVP Bobo ($818K)
CLUSTER — Impact 2/10
May 18, 2026
SEC
Two insiders at Edwards Lifesciences sold a combined ~$884K in open-market shares over a week, representing less than 0.
CLUSTER — Impact 2/10
Inst.
DZ BANK AG Deutsche — ADD
12,811,902 shares ($1.0B)
Price Targets
$96.92
+13.9% upside
Buy
Current $85.11
Low $84.00
Median $100.00
High $110.00
26 analysts
$84.00
$110.00
Analyst Ratings
12Strong Buy
19Buy
11Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 2, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
| Apr 27, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| Apr 24, 2026 | Evercore ISI Group | MAINTAIN | Outperform → Outperform |
| Apr 24, 2026 | Truist Securities | MAINTAIN | Hold → Hold |
| Apr 24, 2026 | Canaccord Genuity | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.74 | $0.73 — $0.76 | 11% YoY | 23 |
| Next Q | $0.74 | $0.72 — $0.79 | 11% YoY | 23 |
| Current FY | $3.01 | $2.97 — $3.05 | 17% YoY | 28 |
| Next FY | $3.37 | $3.30 — $3.52 | 12% YoY | 28 |
Latest Reports
NEUTRAL
CLUSTER
2/10
Three Edwards Lifesciences insiders sold a total of ~$2.18M in open-market sales over a 7-day window, led by the CVP of
May 29, 2026
NEUTRAL
CLUSTER
2/10
Four Edwards Lifesciences insiders sold a total of $982K in stock over a week, with the largest sale by CVP Bobo ($818K)
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $4.2B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.0B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.1B | — |
| STATE STREET CORP | $2.1B | — |
| WELLINGTON MANAGEMENT GROUP LLP | $1.8B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 29, 2026 | Dahl Andrew | SELL | $48.9K |
| May 27, 2026 | BOBO DONALD | SELL | $2.0M |
| May 22, 2026 | Chopra Daveen | SELL | $126.9K |
| May 18, 2026 | Lippis Daniel | M | $45.1K |
| May 18, 2026 | Lippis Daniel | SELL | $50.3K |
Reddit Sentiment
38°
Cool
Bearish
Neutral
Bullish
50 institutional holders with $25.7B total value (320,659,775 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 37 institutions added/increased vs 13 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 52,590,933 | $4.2B | 16.4% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 37,727,792 | $3.0B | 11.8% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 26,407,018 | $2.1B | 8.2% | — |
| 4 | STATE STREET CORP | 26,296,399 | $2.1B | 8.2% | — |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 22,011,101 | $1.8B | 6.9% | — |
| 6 | FMR LLC | 14,503,770 | $1.2B | 4.5% | — |
| 7 | JENNISON ASSOCIATES LLC | 13,066,274 | $1.0B | 4.1% | — |
| 8 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12,811,902 | $1.0B | 4.0% | ADD +65.7% |
| 9 | Ninety One UK Ltd | 12,396,143 | $992.7M | 3.9% | ADD +60.3% |
| 10 | MORGAN STANLEY | 7,060,876 | $565.4M | 2.2% | — |
| 11 | DEUTSCHE BANK AG\ | 6,055,023 | $484.9M | 1.9% | — |
| 12 | Artisan Partners Limited Partnership | 5,201,144 | $416.5M | 1.6% | DOUBLED +345.8% |
| 13 | GOLDMAN SACHS GROUP INC | 5,082,050 | $407.0M | 1.6% | — |
| 14 | Invesco Ltd. | 4,815,350 | $385.6M | 1.5% | ADD +39.1% |
| 15 | Legal & General Group Plc | 4,449,554 | $356.3M | 1.4% | — |
| 16 | BANK OF AMERICA CORP /DE/ | 3,883,419 | $311.0M | 1.2% | DOUBLED +132.4% |
| 17 | ALLIANCEBERNSTEIN L.P. | 3,467,355 | $295.6M | 1.2% | — |
| 18 | DIMENSIONAL FUND ADVISORS LP | 3,636,881 | $291.2M | 1.1% | — |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,557,088 | $284.9M | 1.1% | — |
| 20 | VANGUARD FIDUCIARY TRUST CO | 3,265,355 | $261.5M | 1.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | ADD | 7,732,010 | 12,811,902 | +65.7% | $1.0B | 2026-Q1 |
| Ninety One UK Ltd | ADD | 7,734,946 | 12,396,143 | +60.3% | $992.7M | 2026-Q1 |
| Artisan Partners Limited Partnership | DOUBLED | 1,166,715 | 5,201,144 | +345.8% | $416.5M | 2026-Q1 |
| Invesco Ltd. | ADD | 3,461,198 | 4,815,350 | +39.1% | $385.6M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 1,671,211 | 3,883,419 | +132.4% | $311.0M | 2026-Q1 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | DOUBLED | 1,109,207 | 2,768,995 | +149.6% | $221.7M | 2026-Q1 |
| Neuberger Berman Group LLC | DOUBLED | 328,766 | 2,350,179 | +614.8% | $188.2M | 2026-Q1 |
| Allspring Global Investments Holdings, LLC | DOUBLED | 641,869 | 2,060,891 | +221.1% | $167.5M | 2026-Q1 |
| MARSHALL WACE, LLP | TRIM | 5,925,627 | 1,996,377 | -66.3% | $159.9M | 2026-Q1 |
| NORDEA INVESTMENT MANAGEMENT AB | TRIM | 3,642,618 | 2,024,887 | -44.4% | $157.5M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 428,621 | 1,890,859 | +341.1% | $151.4M | 2026-Q1 |
| Point72 Asset Management, L.P. | DOUBLED | 444,367 | 1,826,537 | +311.0% | $146.3M | 2026-Q1 |
| Woodline Partners LP | ADD | 1,070,634 | 1,768,176 | +65.2% | $141.6M | 2026-Q1 |
| Assenagon Asset Management S.A. | TRIM | 2,286,298 | 1,265,714 | -44.6% | $101.4M | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 408,660 | 1,239,001 | +203.2% | $99.2M | 2026-Q1 |
| Alyeska Investment Group, L.P. | NEW | — | 1,106,336 | — | $88.6M | 2026-Q1 |
| PARNASSUS INVESTMENTS, LLC | ADD | 586,760 | 995,172 | +69.6% | $79.7M | 2026-Q1 |
| Holocene Advisors, LP | TRIM | 2,251,043 | 738,099 | -67.2% | $59.1M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 14,391 | 547,076 | +3701.5% | $43.8M | 2026-Q1 |
| DANSKE BANK A/S | ADD | 346,523 | 534,724 | +54.3% | $42.8M | 2026-Q1 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | TRIM | 1,954,631 | 501,866 | -74.3% | $40.2M | 2026-Q1 |
| ING GROEP NV | ADD | 330,995 | 451,647 | +36.5% | $36.2M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 687,091 | 407,842 | -40.6% | $32.7M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | DOUBLED | 170,268 | 352,315 | +106.9% | $28.2M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 213,495 | 331,593 | +55.3% | $26.6M | 2026-Q1 |
16 unique insiders with 50 transactions. Net insider value: -$3.2M ($0.00 bought, $3.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | Dahl Andrew M. | SVP, Corporate Controller | SELL | 567.527 | $86.08 | $48.9K |
| May 27, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | SELL | 23,145 | $86.42 | $2.0M |
| May 22, 2026 | Chopra Daveen | CVP, TMTT & Surgical | SELL | 1,500 | $84.60 | $126.9K |
| May 18, 2026 | Lippis Daniel J. | CVP, TAVR | EXERCISE | 620 | $72.68 | $45.1K |
| May 18, 2026 | Lippis Daniel J. | CVP, TAVR | SELL | 620 | $81.14 | $50.3K |
| May 15, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | SELL | 9,968 | $82.07 | $818.1K |
| May 12, 2026 | Zovighian Bernard J | CEO | GIFT | 26,640 | — | — |
| May 12, 2026 | Zovighian Bernard J | CEO | SELL | 845 | $78.40 | $66.3K |
| May 11, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | TAX W/H | 7,469 | $79.96 | $597.2K |
| May 11, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | EXERCISE | 13,457 | — | — |
| May 11, 2026 | Lippis Daniel J. | CVP, TAVR | TAX W/H | 362 | $79.96 | $28.9K |
| May 11, 2026 | Zovighian Bernard J | CEO | GIFT | 5,489 | — | — |
| May 11, 2026 | Markowitz Wayne | CVP, JAPAC | SELL | 593 | $79.73 | $47.3K |
| May 11, 2026 | Zovighian Bernard J | CEO | EXERCISE | 47,207 | — | — |
| May 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | TAX W/H | 11,004 | $79.96 | $879.9K |
| May 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | EXERCISE | 19,830 | — | — |
| May 11, 2026 | Zovighian Bernard J | CEO | TAX W/H | 26,198 | $79.96 | $2.1M |
| May 11, 2026 | Chopra Daveen | CVP, TMTT & Surgical | EXERCISE | 13,583 | — | — |
| May 11, 2026 | Chopra Daveen | CVP, TMTT & Surgical | TAX W/H | 7,538 | $79.96 | $602.7K |
| May 8, 2026 | Bruls Annette | CVP, EMEACLA | TAX W/H | 84 | $82.76 | $7.0K |
| May 8, 2026 | LAVIOLETTE PAUL A | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | Lippis Daniel J. | CVP, TAVR | TAX W/H | 450 | $82.76 | $37.2K |
| May 8, 2026 | STONE HEISZ LESLIE | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | GALLAHUE KIERAN | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | Dahl Andrew M. | SVP, Corporate Controller | TAX W/H | 289 | $82.76 | $23.9K |
| May 8, 2026 | Chopra Daveen | CVP, TMTT & Surgical | TAX W/H | 1,141 | $82.76 | $94.4K |
| May 8, 2026 | Davis Leslie C. | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | TAX W/H | 1,661 | $82.76 | $137.5K |
| May 8, 2026 | Feinberg David T | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | TAX W/H | 1,038 | $82.76 | $85.9K |
| May 8, 2026 | VALERIANI NICHOLAS J | Director | AWARD | 5,127 | — | — |
| May 8, 2026 | Sequeira Ramona | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | LORANGER STEVEN R | Director | AWARD | 3,251 | — | — |
| May 8, 2026 | Zovighian Bernard J | CEO | GIFT | 4,222 | — | — |
| May 8, 2026 | Zovighian Bernard J | CEO | TAX W/H | 5,398 | $82.76 | $446.7K |
| May 8, 2026 | Markowitz Wayne | CVP, JAPAC | TAX W/H | 226 | $82.76 | $18.7K |
| May 7, 2026 | Bruls Annette | CVP, EMEACLA | AWARD | 6,650 | — | — |
| May 7, 2026 | Bruls Annette | CVP, EMEACLA | AWARD | 33,700 | — | — |
| May 7, 2026 | Bruls Annette | CVP, EMEACLA | AWARD | 6,650 | — | — |
| May 7, 2026 | Lippis Daniel J. | CVP, TAVR | AWARD | 7,850 | — | — |
| May 7, 2026 | Lippis Daniel J. | CVP, TAVR | TAX W/H | 309 | $83.20 | $25.7K |
| May 7, 2026 | Lippis Daniel J. | CVP, TAVR | AWARD | 39,900 | — | — |
| May 7, 2026 | Lippis Daniel J. | CVP, TAVR | AWARD | 7,850 | — | — |
| May 7, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | TAX W/H | 1,373 | $83.20 | $114.2K |
| May 7, 2026 | Dahl Andrew M. | SVP, Corporate Controller | AWARD | 3,985 | — | — |
| May 7, 2026 | Chopra Daveen | CVP, TMTT & Surgical | AWARD | 9,675 | — | — |
| May 7, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | TAX W/H | 831 | $83.20 | $69.1K |
| May 7, 2026 | Dahl Andrew M. | SVP, Corporate Controller | AWARD | 6,745 | — | — |
| May 7, 2026 | Chopra Daveen | CVP, TMTT & Surgical | TAX W/H | 674 | $83.20 | $56.1K |
| May 7, 2026 | Chopra Daveen | CVP, TMTT & Surgical | AWARD | 49,100 | — | — |
13 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 11 neutral. Avg impact: 3.2/10.
NEUTRAL
CLUSTER
2/10
Three Edwards Lifesciences insiders sold a total of ~$2.18M in open-market sales over a 7-day window
May 29, 2026
NEUTRAL
CLUSTER
2/10
Four Edwards Lifesciences insiders sold a total of $982K in stock over a week, with the largest sale
May 18, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at Edwards Lifesciences sold a combined ~$884K in open-market shares over a week, repre
May 18, 2026
NEUTRAL
CLUSTER
2/10
Two Edwards Lifesciences executives sold a combined $133K in open-market sales over the past week, a
May 12, 2026
NEUTRAL
CLUSTER
2/10
Two Edwards Lifesciences insiders sold a combined $133K in open-market sales over a 7-day window, re
May 12, 2026
NEUTRAL
CLUSTER
2/10
A cluster of insider transactions at Edwards Lifesciences shows one open-market sale by a regional V
May 12, 2026
NEUTRAL
8-K
2/10
Edwards Lifesciences reported the results of its 2026 Annual Meeting, where stockholders approved an
May 8, 2026
NEUTRAL
8-K
3/10
Edwards Lifesciences appoints Theodora Mistras as CFO, effective May 29, 2026, succeeding Scott Ulle
May 4, 2026
BULLISH
8-K
8/10
Edwards Lifesciences reported strong Q1 2026 results with sales up 16.7% to $1.65B and adjusted EPS
Apr 23, 2026
NEUTRAL
CLUSTER
3/10
Two C-suite executives at Edwards Lifesciences sold shares worth $459K in a 7-day window, with open-
Apr 7, 2026
NEUTRAL
DEFA14A
3/10
Edwards Lifesciences Corp (EW) filed a DEFA14A proxy statement for its 2026 Annual Meeting of Stockh
Mar 26, 2026
NEUTRAL
DEFA14A
3/10
Edwards Lifesciences Corp filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting o
Mar 26, 2026
BULLISH
INST-CLUSTER
8/10
Three major institutions — Norges Bank, Two Sigma, and Wells Fargo — collectively added $857.8M in n
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (74% buy). Based on 42 analysts: 12 strong buy, 19 buy, 11 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$96.92 mean target
+13.9% upside
Buy (1.69)
$84.00 Low
$110.00 High
| Metric | Value |
|---|---|
| Current Price | $85.11 |
| Target Low | $84.00 |
| Target Mean | $96.92 |
| Target Median | $100.00 |
| Target High | $110.00 |
| # Analysts | 26 |
| Recommendation | Buy (1.69) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.74 | $0.73 | $0.76 | 10.8% | +0.1% | 1↑ 1↓ | $1.7B | 10.9% | 23 |
| Next Q 2026-09-30 |
$0.74 | $0.72 | $0.79 | 11.2% | -0.0% | 4↑ 12↓ | $1.7B | 8.7% | 23 |
| Current FY 2026-12-31 |
$3.01 | $2.97 | $3.05 | 17.5% | +0.0% | 1↑ 1↓ | $6.7B | 11.2% | 28 |
| Next FY 2027-12-31 |
$3.37 | $3.30 | $3.52 | 12.0% | +0.1% | 3↑ 0↓ | $7.4B | 9.8% | 28 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.742 | |
| 7d ago | $0.742 | |
| 30d ago | $0.742 | +0.001 |
| 60d ago | $0.751 | -0.008 |
| 90d ago | $0.749 | -0.006 |
14 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 2, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Apr 27, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 24, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 24, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
| Apr 24, 2026 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| Apr 24, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 24, 2026 | Baird | MAINTAIN | Neutral | Neutral |
| Apr 13, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 11, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Feb 11, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Feb 11, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
| Feb 11, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 11, 2026 | BTIG | REITERATE | Buy | Buy |
| Jan 20, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Jan 20, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Jan 12, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Jan 12, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 9, 2026 | TD Cowen | UPGRADE | Hold | Buy |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | JP Morgan | UPGRADE | Neutral | Overweight |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| Dec 16, 2025 | Baird | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 12 | 19 | 11 | 0 | 0 | 74% | |
| May 1, 2026 | 12 | 20 | 11 | 0 | 0 | 74% | |
| Apr 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% | |
| Mar 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% | |
| Feb 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% | |
| Jan 1, 2026 | 11 | 19 | 12 | 0 | 0 | 71% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
38°
Cool
Bearish
Neutral
Bullish
4 mentions
0 bullish
2 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 6, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 6, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 29, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 29, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Jun 2, 2026
short_volume
Short Volume: EW — 55.6% short (1.1M / 1.9M)
Short: 1,075,044 | Exempt: 37 | TRF Vol: 1,933,965 | Short Ratio: 55.6% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: EW — 63.9% short (2.3M / 3.6M)
Short: 2,311,782 | Exempt: 305 | TRF Vol: 3,619,560 | Short Ratio: 63.9% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: EW — 5.7M shares, 101,875 trades
Week starting 2026-05-18. Total ATS volume: 5,713,234 shares across 101,875 trades.
May 15, 2026
short_volume
Short Volume: EW — 58.7% short (0.8M / 1.4M)
Short: 848,133 | Exempt: 4,329 | TRF Vol: 1,444,183 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_interest
FTD: EW — 23,698 shares ($1.9M) failed to deliver
Settlement: 20260513, Price: $79.73, FTD Value: $1,889,441.54, EDWARDS LIFESCIENCES CORP
May 11, 2026
dark_pool
Dark Pool: EW — 6.2M shares, 100,611 trades
Week starting 2026-05-11. Total ATS volume: 6,238,648 shares across 100,611 trades.
May 8, 2026
short_volume
Short Volume: EW — 59.3% short (0.8M / 1.4M)
Short: 833,885 | Exempt: 380 | TRF Vol: 1,406,737 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: EW — 63.1% short (0.8M / 1.2M)
Short: 762,254 | Exempt: 500 | TRF Vol: 1,208,762 | Short Ratio: 63.1% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_volume
Short Volume: EW — 64.7% short (0.7M / 1.1M)
Short: 736,458 | Exempt: 0 | TRF Vol: 1,137,613 | Short Ratio: 64.7% | Off-exchange volume (dark pool + OTC)
May 4, 2026
dark_pool
Dark Pool: EW — 5.8M shares, 89,222 trades
Week starting 2026-05-04. Total ATS volume: 5,829,338 shares across 89,222 trades.
May 4, 2026
short_volume
Short Volume: EW — 55.1% short (0.6M / 1.2M)
Short: 637,556 | Exempt: 904 | TRF Vol: 1,157,831 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Apr 28, 2026
short_volume
Short Volume: EW — 62.3% short (1.7M / 2.7M)
Short: 1,667,534 | Exempt: 462 | TRF Vol: 2,678,360 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: EW — 8.8M shares, 117,044 trades
Week starting 2026-04-27. Total ATS volume: 8,818,067 shares across 117,044 trades.
Apr 23, 2026
earnings_calendar
EW Q1 2026 Earnings After Market Close — 2026-04-23
Apr 21, 2026
earnings_calendar
EW Q1 2026 Earnings After Market Close — 2026-04-21